Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): A new antiprotozoal agent

Vaidya, A.B.; Ray, D.K.; Mankodi, N.A.; Paul, T.; Sheth, U.K.

Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): A new antiprotozoal agent

1983

Vaidya, A.B. | Ray, D.K. | Mankodi, N.A. | Paul, T. | Sheth, U.K.

Go.10213 (new antiprotozoal) studied in volunteers for tolerance and in patients with intestinal Entamoeba histolytica for antiamebic activity, good results with only mild and transient side effects, may also be useful against other human protozoal diseases

Show more [+]

AGROVOC Keywords

adolescent aged antiprotozoal agents drug therapy drug toxicity humans nitroimidazoles

Bibliographic information

Published in

British journal of clinical pharmacology

Volume 16 Issue 5 Pagination 517 - 522 ISSN 0306-5251

Other Subjects

Drug evaluation; Male; Entamoeba histolytica; Therapeutic use; Treatment and control; Adverse effects; Adult; Dysentery; Amebic; Middle aged

Language

English

Type

Journal Article; Text

In AGRIS since: 2024-02-27

Format: MODS

Data Provider

This bibliographic record has been provided by National Agricultural Library

Discover this data provider's collection in AGRIS

Lookup at Google Scholar

If you notice any incorrect information relating to this record, please contact us at [email protected]

FAO AGRIS - International System for Agricultural Science and Technology

Share

Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): A new antiprotozoal agent

1983

AGROVOC Keywords

Bibliographic information